DocGo

DocGo

DocGo was founded in 2015 by Stan Vashovsky, who initially focused on non-emergency medical transportation before expanding into the mobile healthcare category. The company's revenue is generated from contracts with hospital systems, health insurers, and government entities including municipal migrant care programs, rather than from a portfolio of invested capital. This operating-company posture places it outside the traditional family-office or fund-manager structure, making its primary economic driver the provision of medical services rather than asset allocation. The firm's Ambulnz subsidiary operates ambulance services, while its Rapid Reliable Testing division is responsible for on-site diagnostics. DocGo's model allocates resources toward direct service delivery infrastructure. The company's deployment includes mobile health units staffed by nurse practitioners and paramedics, allowing it to perform in-home urgent care, post-discharge follow-ups, and event medical services. In the United Kingdom, DocGo entered the market through ambulance transport contracts with the National Health Service. The firm also secured high-value, short-term contracts during the COVID-19 pandemic for testing and vaccination logistics, which generated significant surge revenue. As of 2023, management emphasized a transition toward recurring care models tied to value-based care arrangements with health plans and health systems. With a public listing on the Nasdaq under ticker DCGO, DocGo operates from its New York base. The company has been subject to scrutiny over its migrant care contracts in New York City, which drove a substantial portion of its 2023 revenue but also attracted media and auditor inquiries. In January 2024, DocGo disclosed that its audit firm, CohnReznick, resigned amid a dispute over the classification of certain liabilities and internal control remediation costs (per the company's 8-K filing, January 2024). The firm immediately retained a new auditor. This operational turbulence reflects a governance structure more aligned with a public operating company than a private investment office. The structural distinction is DocGo's identity as a publicly traded service provider managing a workforce of thousands of clinicians and drivers, funded by equity and debt markets rather than family wealth. Its capital allocation decisions — fleet purchases, technology development for its dispatch platform, and M&A for regional expansion — serve an operating P&L. This separates it from a family office or fund manager by both mandate and regulatory profile, with decision rights distributed across a board and executive team accountable to public shareholders.